Home › Immunoblastic Lymphadenopathy › Florida
Immunoblastic Lymphadenopathy clinical trials in Florida
4 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in Florida.
Cities in Florida
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine, Miami
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
- Clinical Trial Site, Miami
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06393738Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04803201A Registry for People With T-cell Lymphoma
- University of Miami (Data Collection Only), Miami
- Moffitt Cancer Center (Data Collection Only), Tampa
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.